EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

GPX3 suppresses lung adenocarcinoma progression through HSPB1 ubiquitination and Hippo pathway activation

Sixuan Wu, He Huang, Junfan Pan, Yaqin Zheng, Qihong Pan, Sihui Chen, Jing Zhang, Yuehua Li, Yiquan Xu

Cell Reports · 2026

DOI: 10.1016/j.celrep.2026.117923 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026. Verfasst von Sixuan Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, China; Department of Oncology, The First Affiliated Hos…. Hauptthemen laut MEDLINE: Lung Neoplasms, Adenocarcinoma of Lung, Glutathione Peroxidase, Protein Serine-Threonine Kinases. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fujian Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsAdenocarcinoma of LungGlutathione PeroxidaseProtein Serine-Threonine KinasesDisease ProgressionHeat-Shock ProteinsHSP27 Heat-Shock ProteinsHumansUbiquitinationCell Line, TumorHippo Signaling PathwaySignal TransductionCell ProliferationAnimalsGene Expression Regulation, NeoplasticPrognosisApoptosis

Stichwörter der Autor:innen

CP: cancerGPX3HSPB1 ubiquitinationHippo signaling pathwaylung adenocarcinomaprognostic model

Substanzen

Glutathione PeroxidaseProtein Serine-Threonine KinasesGPX3 protein, humanHeat-Shock ProteinsHSP27 Heat-Shock Proteins

Autor:innen und Institutionen

  • Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, China; Department of Oncology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 42…
  • Endoscopy Center, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
  • Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, China.
  • Interdisciplinary Institute of Medical Engineering of Fuzhou University, Fuzhou 350108, China.
  • Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, China; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou…
  • Department of Oncology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 421001, China. Electronic address: liyuehua2020@stu.usc.edu.cn.

Förderung

  • Fujian Provincial Natural Science Foundation

Zitieren

APA

Wu, S., Huang, H., Pan, J., Zheng, Y., Pan, Q., Chen, S., Zhang, J., Li, Y., & Xu, Y. (2026). GPX3 suppresses lung adenocarcinoma progression through HSPB1 ubiquitination and Hippo pathway activation. Cell Reports. https://doi.org/10.1016/j.celrep.2026.117923

Vancouver

Wu S, Huang H, Pan J, Zheng Y, Pan Q, Chen S, et al. GPX3 suppresses lung adenocarcinoma progression through HSPB1 ubiquitination and Hippo pathway activation. Cell Reports. 2026. doi:10.1016/j.celrep.2026.117923

BibTeX
@article{Wu2026,
  author = {Wu, Sixuan and Huang, He and Pan, Junfan and Zheng, Yaqin and Pan, Qihong and Chen, Sihui and Zhang, Jing and Li, Yuehua and Xu, Yiquan},
  title = {GPX3 suppresses lung adenocarcinoma progression through HSPB1 ubiquitination and Hippo pathway activation},
  journal = {Cell Reports},
  year = {2026},
  doi = {10.1016/j.celrep.2026.117923}
}
Kostenlos starten →